Ticagrelor (90mg) is manufactured by Astrazeneca Pharma India Ltd
Brilinta 90mg Tablet is an antiplatelet medication. It works by preventing platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
This is available in a 1 Strip of 14 Tablet format with an MRP of ₹591.
If you experience any persistent or severe side effects, consult your doctor immediately.
Caution is advised when consuming alcohol with Brilinta 90mg Tablet. Please consult your doctor.
It is not known whether Brilinta 90mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Dizziness, confusion, vertigo, and syncope have been reported in some patients. If you experience such symptoms, be cautious while driving or using machines.
Brilinta 90mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Brilinta 90mg Tablet is recommended. Limited information is available on the use of Brilinta 90mg Tablet in renal dialysis patients.
Brilinta 90mg Tablet is safe to use in patients with liver disease. No dose adjustment of Brilinta 90mg Tablet is recommended. Use of Brilinta 90mg Tablet is not recommended in patients with severe liver disease.
Brilinta 90mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Brilinta 90mg Tablet during breastfeeding is not available. Please consult your doctor.














100% Genuine
Medicines
No
Return
Online
Payment Only
Astrazeneca Pharma India Ltd
100% Genuine
Medicines
No
Return
Online
Payment Only
Astrazeneca Pharma India Ltd